Boston Partners Raises Stake in Bath & Body Works, Inc. $BBWI

Key Points

• Boston Partners significantly increased its holdings in Bath & Body Works by 289.7% during the first quarter, owning approximately 0.44% of the company valued at $28.3 million.
• Bath & Body Works reported a Q1 revenue of $1.40 billion and an earnings per share of $0.49, exceeding analysts' expectations.
• The company declared a quarterly dividend of $0.20 per share, indicating an annualized yield of 2.8%.

Boston Partners boosted its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 289.7% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 937,024 shares of the company's stock after buying an additional 696,555 shares during the quarter. Boston Partners owned 0.44% of Bath & Body Works worth $28,292,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the business. Caitong International Asset Management Co. Ltd raised its holdings in shares of Bath & Body Works by 9,569.1% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 11,893 shares of the company's stock valued at $361,000 after purchasing an additional 11,770 shares in the last quarter. GKV Capital Management Co. Inc. acquired a new stake in shares of Bath & Body Works in the 1st quarter valued at $69,000. Russell Investments Group Ltd. raised its holdings in shares of Bath & Body Works by 10.8% in the 1st quarter. Russell Investments Group Ltd. now owns 191,916 shares of the company's stock valued at $5,819,000 after purchasing an additional 18,708 shares in the last quarter. HighTower Advisors LLC raised its holdings in shares of Bath & Body Works by 212.7% in the 1st quarter. HighTower Advisors LLC now owns 17,422 shares of the company's stock valued at $528,000 after purchasing an additional 11,850 shares in the last quarter. Finally, CCM Investment Group LLC acquired a new stake in shares of Bath & Body Works in the 1st quarter valued at $764,000. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Stock Performance

Bath & Body Works stock traded down $0.2050 during midday trading on Wednesday, hitting $29.6150. 4,374,594 shares of the company's stock were exchanged, compared to its average volume of 4,617,455. Bath & Body Works, Inc. has a 12-month low of $24.94 and a 12-month high of $41.87. The stock has a market cap of $6.27 billion, a price-to-earnings ratio of 7.90, a price-to-earnings-growth ratio of 1.00 and a beta of 1.54. The firm's 50 day simple moving average is $30.12 and its 200 day simple moving average is $31.14.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings data on Thursday, May 29th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.47 by $0.02. Bath & Body Works had a net margin of 11.10% and a negative return on equity of 47.44%. The company had revenue of $1.40 billion for the quarter, compared to the consensus estimate of $1.42 billion. During the same period last year, the firm posted $0.38 EPS. Bath & Body Works's revenue for the quarter was up 2.9% on a year-over-year basis. Bath & Body Works has set its Q2 2025 guidance at 0.330-0.380 EPS. On average, equities research analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 5th. Shareholders of record on Friday, August 22nd will be given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend is Friday, August 22nd. Bath & Body Works's dividend payout ratio (DPR) is presently 21.33%.

Analysts Set New Price Targets

BBWI has been the topic of a number of analyst reports. Wall Street Zen lowered shares of Bath & Body Works from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. The Goldman Sachs Group reduced their price objective on shares of Bath & Body Works from $44.00 to $43.00 and set a "buy" rating on the stock in a report on Friday, May 30th. JPMorgan Chase & Co. raised their price objective on shares of Bath & Body Works from $40.00 to $46.00 and gave the company an "overweight" rating in a report on Monday, July 28th. Wells Fargo & Company raised their price objective on shares of Bath & Body Works from $40.00 to $44.00 and gave the company an "overweight" rating in a report on Wednesday, May 14th. Finally, Telsey Advisory Group reaffirmed an "outperform" rating and issued a $38.00 target price (down from $43.00) on shares of Bath & Body Works in a research report on Thursday, May 29th. Fourteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $42.06.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.